
Capricor Therapeutics Set to Present at Leerink’s Global Healthcare Conference in 2025
Capricor Therapeutics Announces Participation in Leerink’s Global Healthcare Conference 2025 Capricor Therapeutics, a pioneering biotechnology company specializing in the development of transformative cell and exosome-based therapeutics for the treatment of rare diseases, recently announced its upcoming participation in Leerink’s Global Healthcare Conference 2025. The event is scheduled to take place from March 10-12, 2025, in…